Europe — EMA
Inaladuo Accuhaler (Fluticasone Propionate, Salmeterol)
GNH USA supplies Inaladuo Accuhaler (Fluticasone propionate and salmeterol), a inhaled corticosteroid/long‑acting β2‑agonist for asthma and COPD maintenance
Request sourcing
What is Fluticasone Propionate, Salmeterol?
Fluticasone propionate and salmeterol, the active ingredient in Inaladuo Accuhaler, is an inhaled corticosteroid/long‑acting β2‑agonist (ICS/LABA) combination presented as a dry powder inhaler for inhalation use. It treats asthma and chronic obstructive pulmonary disease (COPD) as a maintenance therapy in adults and adolescents, helping to control inflammation and keep airways open. The device delivers a consistent dose of medication to the lungs, reducing airway inflammation and maintaining bronchodilation.
GNH USA supplies Inaladuo Accuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Fluticasone Propionate, Salmeterol used for?
Inaladuo Accuhaler, an inhaled corticosteroid/long‑acting β2‑agonist (ICS/LABA) combination, is used for maintenance therapy in obstructive airway diseases.
Asthma: improves symptom control and reduces the frequency of exacerbations in patients requiring daily maintenance therapy. Chronic obstructive pulmonary disease (COPD): enhances lung function, decreases breathlessness and lowers the risk of COPD exacerbations.
What are the side effects of Fluticasone Propionate, Salmeterol?
Inhaled use of Inaladuo Accuhaler may be associated with several adverse reactions.
Common Side Effects: - Oral thrush (candidiasis): fungal infection of the mouth or throat. - Hoarseness or dysphonia: voice changes due to local steroid effect. - Cough or throat irritation: mild irritation after inhalation. - Headache: mild to moderate headache.
Serious or Rare Side Effects: - Paradoxical bronchospasm: sudden worsening of breathing requiring medical attention. - Adrenal suppression: reduced cortisol production with prolonged high‑dose use. - Allergic reactions: rash, urticaria or anaphylaxis.
What precautions apply to Fluticasone Propionate, Salmeterol?
When prescribing Inaladuo Accuhaler, consider the following precautions.
Assess infection risk: monitor for oral candidiasis and treat promptly. Use spacer or rinse mouth: reduce local steroid effects and improve drug delivery. Monitor lung function: adjust therapy based on symptom control and spirometry results. Avoid abrupt discontinuation: taper if long‑term high‑dose therapy is needed. Store at ambient temperature: keep inhaler below 25 °C, protect from moisture and direct sunlight.
What does Fluticasone Propionate, Salmeterol interact with?
Inaladuo Accuhaler may interact with other medicines; review patient medication lists.
Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may increase systemic steroid exposure. - Non‑selective beta‑blockers: can reduce the bronchodilator effect of salmeterol. - MAO inhibitors or tricyclic antidepressants: may increase cardiovascular adverse effects.
Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypokalemia risk when combined with a β2‑agonist. - Theophylline: may increase the likelihood of tachycardia and tremor.



